Suppr超能文献

宫颈残端癌的放射治疗

Radiation management of carcinoma of the cervical stump.

作者信息

Prempree T, Patanaphan V, Scott R M

出版信息

Cancer. 1979 Apr;43(4):1262-73. doi: 10.1002/1097-0142(197904)43:4<1262::aid-cncr2820430414>3.0.co;2-#.

Abstract

In spite of a low incidence of carcinoma of the cervical stump at the present time, the management of this interesting disease deserves special attention because of the success which can be obtained with proper treatment. We have reviewed our cervical stump cases treated at the University of Maryland Hospital, Department of Radiation Therapy, from 1962 to 1973. Of 107 cases treated, only 100 cases were "true cases" of carcinoma of the stump and were eligible for this study. 7 cases were excluded from the study because they were probably coincidental carcinomas and were treated soon after subtotal hysterectomy. The lesions were staged according to the FIGO system. 93 cases (93%) were invasive squamous cell carcinoma, 6 cases (6%) adenocarcinoma and 1 case (1%) transitional cell carcinoma. Of 100 cases with a minimum 5 year follow-up, the absolute 5-year cure rate for various clinical stages is as follows: Stage I 83.3% (20/24); Stage IIA 75.0% (9/12); Stage IIB 62.5% (20/32); Stage IIIA 50% (1/2); Stage IIIB 48% (12/25); Stage IV 20% (1/5). The overall absolute 5-year cure rate for all stages combined is 63% (63/100) compatible with a series reported by M.D. Anderson. A better result in Stage IIIB as compared to several previous reports is thought to be due to extensive and aggressive interstitial radium therapy properly combined with external supervoltage irradiation. Techniques of treatment stage by stage including computerized dosimetry will be discussed along with complications and failures.

摘要

尽管目前宫颈残端癌的发病率较低,但由于恰当治疗能够取得成功,这种有趣的疾病的管理值得特别关注。我们回顾了1962年至1973年在马里兰大学医院放射治疗科治疗的宫颈残端病例。在治疗的107例病例中,只有100例是残端癌的“真正病例”,有资格纳入本研究。7例被排除在研究之外,因为它们可能是巧合癌,在次全子宫切除术后不久就接受了治疗。病变根据国际妇产科联盟(FIGO)系统进行分期。93例(93%)为浸润性鳞状细胞癌,6例(6%)为腺癌,1例(1%)为移行细胞癌。在100例至少随访5年的病例中,各临床分期的绝对5年治愈率如下:Ⅰ期83.3%(20/24);ⅡA期75.0%(9/12);ⅡB期62.5%(20/32);ⅢA期50%(1/2);ⅢB期48%(12/25);Ⅳ期20%(1/5)。所有分期综合的总体绝对5年治愈率为63%(63/100),与MD安德森癌症中心报告的系列结果相符。与之前的几份报告相比,ⅢB期的结果更好,被认为是由于广泛且积极的组织间镭疗与体外超高压照射恰当联合。将讨论逐阶段的治疗技术,包括计算机剂量测定法以及并发症和治疗失败情况。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验